Table 1 Characteristics of women diagnosed with HIV, Israel, 2010–2018
All years (2010–2018) N = 763 | 2010–2012 N = 246 | 2013–2015 N = 257 | 2016–2018 N = 260 | p value | |
|---|---|---|---|---|---|
Median age at diagnosis (IQR) | 38 (31–46) | 37 (29–43) | 37 (30–46) | 40 (34–48) | < 0.001 |
Place of birth, n (%) | |||||
SSA | 246 (32.2) | 110 (44.7) | 64 (24.9) | 72 (27.7) | |
FSU | 314 (41.2) | 77 (31.3) | 107 (41.6) | 130 (50) | |
Israel | 87 (11.4) | 30 (12.2) | 32 (12.5) | 25 (9.6) | < 0.001 |
Other/Unknown | 116 (15.2) | 29 (11.8) | 54 (21) | 33 (12.7) | |
Risk Groups, n (%) | |||||
Sexual contact | 629 (82.4) | 202 (82.1) | 211 (82.1) | 216 (83.1) | |
IDU | 83 (10.9) | 34 (13.8) | 33 (12.8) | 16 (6.2) | 0.001 |
Other/Unknown | 51 (6.7) | 10 (4.1) | 13 (5.1) | 28 (10.8) | |
HIV-1 Subtype (N) | 337 | 123 | 109 | 105 | |
A, n (%) | 130 (38.6) | 45 (36.6) | 40 (36.7) | 45 (42.9) | |
B, n (%) | 34 (10.1) | 10 (8.1) | 17 (15.6) | 7 (6.7) | |
C, n (%) | 141 (41.8) | 61 (49.6) | 44 (40.4) | 36 (34.3) | 0.014 |
G/AG, n (%) | 23 (6.8) | 3 (2.4) | 7 (6.4) | 13 (12.4) | |
Other, n (%) | 9 (2.7) | 4 (3.3) | 1 (0.9) | 4 (3.8) | |
CD4 (cells/mm*3) (n = 171), median (IQR) | 263 (121–466) | 285 (146–496) | 270 (133–492) | 234 (73–394) | 0.283 |
VL (Log c/mL) (n = 236), median (IQR) | 4.5 (3.9–5.4) | 4.4 (3.7–5.4) | 4.6 (4.1–5.2) | 4.8 (4.3–5.3) | 0.519 |